SCHEMBL7074672

SCHEMBL7074672

CCC(CC)C1CN(OC(=O)OC(C)(C)C)CC(O)C1c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 8/20 0.33
TP53 P04637 7/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
OPRK1 P41145 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
ALOX12 P18054 1/20 0.30
CACNA1H O95180 1/20 0.30
MC4R P32245 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960697 0.88 MEN1 (0.33) MEN1KMT2AGAAMC4R
SCHEMBL6951399 0.82 SLC6A3 (0.37) MDM2KMT2AMAOAMAOBALDH1A1
SCHEMBL6041346 0.78 CCR1 (0.37) MDM2
SCHEMBL6955257 0.76 MIF (0.35)
SCHEMBL6042593 0.75 SLC6A3 (0.37) OPRK1ALDH1A1GAA
SCHEMBL6958285 0.73
SCHEMBL6625881 0.73 KDM1A (0.32) ALDH1A1GAASMN1; SMN2
SCHEMBL6958920 0.73 MDM2 (0.34) MDM2
SCHEMBL6951574 0.72 TACR1 (0.37)
SCHEMBL1942520 0.72 PDE4B (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed